Skip to the page

Data / Form D filings / Bioliberty Ltd

Bioliberty Ltd: Form D filings

Bioliberty Ltd, a technology company in Edinburgh, United Kingdom, filed 2 Form D notices with the SEC in 2026. The latest, on October 26, 2026, reports $335,906 sold of a $660,905 offering to 2 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
3F CANNING EXCHANGE 10 CANNING STREET, Edinburgh, United Kingdom, EH3 8
Phone
(816) 753-1000
Industry
Other Technology
Entity type
Other
Incorporated in
United Kingdom
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
2151818

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Oct 26, 2026New notice$660,905$335,906$324,9992Oct 16, 2026sec.gov
Aug 27, 2026New notice$2,947,097$2,947,09712Jul 31, 2026sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Barry HextallExecutive Officer
Rowan ArmstrongDirector
Conan BradleyDirector
Shea QuinnDirector
Ross O'HanlonDirector
Ramy El-MadanyDirector
David O'ReillyDirector
Russell BaileyDirector
Dana StraussDirector
Albert NichollDirector

Every Form D from the week of Oct 26, 2026 · All recent Other Technology filings

Read from SEC EDGAR. Amount sold is what Bioliberty Ltd reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.